About this Journal Submit a Manuscript Table of Contents
Case Reports in Medicine
Volume 2013 (2013), Article ID 459753, 5 pages
http://dx.doi.org/10.1155/2013/459753
Case Report

False Positive 18F-FDG Uptake in Mediastinal Lymph Nodes Detected with Positron Emission Tomography in Breast Cancer: A Case Report

1Department of Radiation Oncology, Acibadem Adana Hospital, Acibadem University School of Medicine, Seyhan, 01130 Adana, Turkey
2Department of Nuclear Medicine, Acibadem Adana Hospital, Seyhan, 01130 Adana, Turkey
3Department of Internal Medicine, Acibadem Adana Hospital, Acibadem University School of Medicine, Seyhan, 01130 Adana, Turkey
4Department of Thoracic Surgery, Inonu University School of Medicine, 44000 Malatya, Turkey

Received 20 December 2012; Accepted 11 February 2013

Academic Editor: Bruno Megarbane

Copyright © 2013 Gamze Uğurluer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), “Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials,” The Lancet, vol. 365, no. 9472, pp. 1687–1717, 2005. View at Publisher · View at Google Scholar
  3. T. F. Çermik, A. Mavi, S. Basu, and A. Alavi, “Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 3, pp. 475–483, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. T. A. Heusner, S. Kuemmel, L. Umutlu et al., “Breast cancer staging in a single session: whole-body PET/CT mammography,” Journal of Nuclear Medicine, vol. 49, no. 8, pp. 1215–1222, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. J. M. Reich, J. P. Mullooly, and R. E. Johnson, “Linkage analysis of malignancy-associated sarcoidosis,” Chest, vol. 107, no. 3, pp. 605–613, 1995. View at Scopus
  6. G. Antoch, F. M. Vogt, L. S. Freudenberg et al., “Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology,” Journal of the American Medical Association, vol. 290, no. 24, pp. 3199–3206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Fujiuchi, T. Saeki, H. Takeuchi et al., “A false positive for metastatic lymph nodes in the axillary region of a breast cancer patient following mastectomy,” Breast Cancer, vol. 18, no. 2, pp. 141–144, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Fuster, J. Duch, P. Paredes et al., “Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures,” Journal of Clinical Oncology, vol. 26, no. 29, pp. 4746–4751, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Groheux, E. Hindié, M. Delord et al., “Prognostic impact of 18FDG-PET-CT findings in clinical stage III and IIB breast cancer,” Journal of the National Cancer Institute, vol. 104, no. 24, pp. 1879–1887, 2012. View at Publisher · View at Google Scholar
  10. W. B. Eubank, D. A. Mankoff, J. Takasugi et al., “18Fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer,” Journal of Clinical Oncology, vol. 19, no. 15, pp. 3516–3523, 2001. View at Scopus
  11. S. Ataergin, N. Arslan, A. Ozet, and M. A. Ozguven, “Abnormal 18F-FDG uptake detected with positron emission tomography in a patient with breast cancer: a case of sarcoidosis and review of the literature,” Case Reports in Medicine, vol. 2009, Article ID 785047, 4 pages, 2009. View at Publisher · View at Google Scholar
  12. B. Zangheri, C. Messa, M. Picchio, L. Gianolli, C. Landoni, and F. Fazio, “PET/CT and breast cancer,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 31, supplement 1, pp. S135–S142, 2004. View at Scopus
  13. D. H. Reddy and E. B. Mendelson, “Incorporating new imaging models in breast cancer management,” Current Treatment Options in Oncology, vol. 6, no. 2, pp. 135–145, 2005. View at Scopus
  14. B. Keam, S.-A. Im, Y. Koh et al., “Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy,” Breast Cancer, 2012. View at Publisher · View at Google Scholar
  15. D. A. Podoloff, R. H. Advani, C. Allred et al., “NCCN Task Force report: Positron Emission Tomography (PET)/Computed Tomography (CT) scanning in cancer,” JNCCN Journal of the National Comprehensive Cancer Network, vol. 5, supplement 1, pp. S1–S22, 2007.
  16. D. Wu and S. S. Gambhir, “Positron emission tomography in diagnosis and management of invasive breast cancer: current status and future perspectives,” Clinical Breast Cancer, vol. 4, supplement 1, pp. S55–S63, 2003. View at Scopus
  17. G. J. R. Cook, E. A. Wegner, and I. Fogelman, “Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging,” Seminars in Nuclear Medicine, vol. 34, no. 2, pp. 122–133, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. B. M. Hunt, E. Vallières, G. Buduhan, R. Aye, and B. Louie, “Sarcoidosis as a benign cause of lymphadenopathy in cancer patients,” American Journal of Surgery, vol. 197, no. 5, pp. 629–632, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Bhatia, Y. Kumar, and A. S. Kathpalia, “Granulomatous inflammation in lymph nodes draining cancer: a coincidence or a significant association!,” International Journal of Medical Sciences, no. 2, pp. 13–16, 2009.